This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

OTI Disclaimer:

Due to the inherent nature of this plasmid, standard methods to replicate additional amounts of DNA in E. coli are highly likely to result in mutations and/or rearrangements. Therefore, OriGene does not guarantee the capability to replicate this plasmid DNA. Additional amounts of DNA can be purchased from OriGene with batch-specific, full-sequence verification at a reduced cost. Please contact our customer care team at custsupport@origene.com or by calling 301.340.3188 option 3 for pricing and delivery.

The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info

The Reference Sequence (RefSeq) collection provides a comprehensive, integrated, non-redundant set of sequences. This database is built by NCBI, and, provides only a single record for each gene/transcript. More details.
Due to SNPs, each gene/transcript has many variations in the sequence; those variations are naturally occurring. Therefore, Refseq is one curated sequence, not to be perceived as the wild type.

Synonyms: BCC7; LFS1; P53; TRP53

RefSeq Size: 2629

RefSeq ORF: 1182

LocusID: 7157

Cytogenetic: 17p13.1

Domains: P53

Gene Summary: This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]